Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Arjun Vasant Balar, Dean F. Bajorin, Sanjeev Mariathasan et al.|The Lancet|2016

Cited by 2.2k